MedPath

Visual Erotica, EMG, and Sexual Psychophysiological Arousal (VESPA)

Completed
Conditions
Sexual Arousal
Registration Number
NCT01700361
Lead Sponsor
University of British Columbia
Brief Summary

This study will examine whether measurement of pelvic floor muscle sEMG activity is responsive to explicit sexual stimuli, and whether it correlates with self-reports of sexual arousal in healthy women. Participants' vaginal, labial and anal sEMG readings will be monitored during exposure to neutral, erotic and anxiety-provoking films. Participants will also be required to provide subjective ratings of sexual arousal before and after each film. If pelvic floor sEMG is validated as a psychophysiological measure, these findings may have important clinical and research implications by providing a greater understanding of the mechanisms involved in sexual arousal and for providing a relatively easy method of assessing sexual arousal in a clinical or research setting.

Detailed Description

HYPOTHESES:

1. Investigators hypothesize that, relative to the neutral films, PFM EMG activity will significantly increase in response to the erotic film as measured by the labial, anal, and vaginal EMG probes.

2. Investigators hypothesize that, relative to the anxiety-provoking film, PFM EMG activity will significantly increase in response to the erotic film as measured by the labial, anal, and vaginal EMG probes.

3. Investigators hypothesize that continuously measured subjective sexual arousal (via the arousometer) will correlate significantly with PFM EMG activity during the erotic film.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
15
Inclusion Criteria
  • Must be female, between the ages of 19-45
  • Must be premenopausal
  • Must be previously sexually active
  • Must be fluent in English
Read More
Exclusion Criteria
  • Lack of fluency in English
  • Not female between the ages of 19-45
  • Not previously sexually active
  • Any previous deliveries, either vaginal or by c-section
  • Any sexual arousal disorder
  • Any genital pain or pelvic pain disorders
  • Any bowel or bladder syndromes (e.g. interstitial cystitis, irritable bowel disease, Chron's disease)
  • Any urinary incontinence or pelvic organ prolapse
  • Undergone medically induced menopause
  • Undergone total or partial hysterectomy
  • Undergone surgery for incontinence or prolapse
  • Using estrogen suppression medication
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pelvic floor muscle sEMG activityThis study involves 1 testing session approximately 20 minutes in duration

Changes in pelvic floor muscle activity in responsive to exposure to explicit sexual stimuli will be assessed using pelvic floor surface electromyography (sEMG).

Secondary Outcome Measures
NameTimeMethod
Sexual FunctionThis study involves 1 testing session approximately 20 minutes in duration

Self-reported sexual function will be measured using the Female Sexual Function Inventory (FSFI; Rosen et al., 2000) and the Derogatis Sexual Functioning Inventory (DSFI; Derogatis \& Melisaratos, 1979).

Sexual ArousalThis study involves 1 testing session approximately 20 minutes in duration

Self-report sexual arousal will be measured with the Sexual Arousability Inventory (SAI ; Hoon, Hoon, \& Wincze, 1976)

Trial Locations

Locations (1)

Department of Gynaecology

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath